SCHEMBL26102249

SCHEMBL26102249

COc1ccc(CNc2ccc(CC(=O)N3CC(CO)C3)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.57
HPGD P15428 2/20 0.57
SMN1; SMN2 Q16637 1/20 0.54
FFAR1 O14842 1/20 0.51
MAPT P10636 3/20 0.50
GAA P10253 2/20 0.50
HIF1A Q16665 1/20 0.50
RAB9A P51151 4/20 0.48
NPC1 O15118 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
LMNA P02545 1/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
GFER P55789 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23747578 0.87 SMN1; SMN2 (0.59) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A
SCHEMBL26099188 0.83 SMN1; SMN2 (0.54) ALDH1A1HPGDSMN1; SMN2FFAR1MAPT
SCHEMBL26098711 0.82 SMN1; SMN2 (0.66) ALDH1A1HPGDSMN1; SMN2FFAR1MAPT
SCHEMBL26102577 0.82 RAB9A (0.54) ALDH1A1FFAR1MAPTGAAHIF1A
SCHEMBL26101450 0.81 MAPT (0.50) ALDH1A1HPGDSMN1; SMN2FFAR1MAPT
SCHEMBL23747788 0.79 SMN1; SMN2 (0.55) ALDH1A1HPGDSMN1; SMN2MAPTGAA
SCHEMBL23747787 0.79 SMN1; SMN2 (0.55) ALDH1A1HPGDSMN1; SMN2MAPTGAA
SCHEMBL23747343 0.78 SMN1; SMN2 (0.59) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A
SCHEMBL26101541 0.78 HRH3 (0.52) ALDH1A1HPGDSMN1; SMN2FFAR1MAPT
SCHEMBL26099623 0.77 SMN1; SMN2 (0.58) ALDH1A1HPGDSMN1; SMN2MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133132-A1 NAMPT MODULATORS NAMPT, MC4R, SIRT1 ALDH1A1 2019/4885HPGD 355/4885SMN1; SMN2 1161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.